Skip to content

Clinical trials

Observational Hematologic Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Observational Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20203
20212
20224
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Enrolling by invitation3
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Munich Leukemia Laboratory2
AvenCell Therapeutics, Inc.1
Beckman Coulter, Inc.1
CRISPR Therapeutics AG1
Centre Hospitalier Universitaire Vaudois1
European Society for Blood and Marrow Transplantation1
Kiadis Pharma1
Kite, A Gilead Company1
Prof. Dr. Thomas Luft1
Technical University of Munich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms14
Hematologic Diseases2
Leukemia2
Leukemia, Myeloid, Acute2
Lymphoma2
Autoimmune Diseases1
Central Nervous System Infections1
Graft vs Host Disease1
Infections1
Influenza, Human1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.